Cargando…
Exome sequencing of glioblastoma-derived cancer stem cells reveals rare clinically relevant frameshift deletion in MLLT1 gene
BACKGROUND: Glioblastoma multiforme (GBM) is a heterogeneous CNS neoplasm which causes significant morbidity and mortality. One reason for the poor prognostic outcome of GBM is attributed to the presence of cancer stem cells (CSC) which confer resistance against standard chemo- and radiotherapeutics...
Autores principales: | Marei, Hany E., Althani, Asmaa, Afifi, Nahla, Hasan, Anwarul, Caceci, Thomas, Felsani, Armando, Tringali, Giuseppe, Cifola, Ingrid, Pozzoli, Giacomo, Cenciarelli, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740446/ https://www.ncbi.nlm.nih.gov/pubmed/34996478 http://dx.doi.org/10.1186/s12935-021-02419-4 |
Ejemplares similares
-
Current progress in chimeric antigen receptor T cell therapy for glioblastoma multiforme
por: Marei, Hany E., et al.
Publicado: (2021) -
p53 signaling in cancer progression and therapy
por: Marei, Hany E., et al.
Publicado: (2021) -
Pandemic COVID-19 caused by SARS-CoV-2: genetic structure, vaccination, and therapeutic approaches
por: Marei, Hany E., et al.
Publicado: (2021) -
Glioma extracellular vesicles for precision medicine: prognostic and theragnostic application
por: Marei, Hany E., et al.
Publicado: (2022) -
Potential of Stem Cell-Based Therapy for Ischemic Stroke
por: Marei, Hany E., et al.
Publicado: (2018)